Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2017-04-24Sell5,000331,103$31.46157.35.21331,103 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2017-04-03Sell5,000306,846$31.3156.55.7578,236 (Direct)
199,487 (Held by the Popovits 2010 Trust)
12,298 (Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2017-03-23Sell5,000331,103$31.26156.35.89331,103 (Direct)
Leber LauraChief Communication Officer2017-03-20Sell3,07214,627$31.8897.943.8314,627 (Direct)
Cole G BradleyCOO2017-03-08Sell5,71039,528$31.55180.154.9139,528 (Direct)
Popovits Kimberly JPresident and CEO2017-03-06Sell5,000308,210$31.09155.456.4778,236 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Shak StevenChief Scientific Officer2017-02-23Sell5,000331,103$29.36146.812.74331,103 (Direct)
Febbo Phillip G.Chief Medical Officer2017-02-16Sell2,49520,644$30.0975.071020,644 (Direct)
Cole G BradleyCOO2017-02-15Sell5,00039,728$2914514.1439,728 (Direct)
Shak StevenChief Scientific Officer2017-01-23Sell5,000327,207$27.28136.421.33327,207 (Direct)
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.113.2835,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.058.1335,882 (Direct)
Popovits Kimberly JPresident and CEO2016-12-05Sell5,000289,594$30.02150.110.2659,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.274.3214,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.554.38327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.411.5235,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.4414.6159,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.958.92327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.598.2135,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.0411.5226,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.1523.37327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.6420.7635,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.221.51327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.02270222.5
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.3514.6535,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.2215.1729,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.120.71327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.224.2535,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8528.44327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.124.3435,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.9218.2132,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.613819.9334,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.0121.6915,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$285618.2131,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.330.16326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.0818.2124,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.182.996,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.764.4527,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-1.5824,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.0413.1227,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.1912.8512,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.6612.8524,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1227.1630,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9830.5730,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.1220.2330,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9626.1430,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.1620.1929,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.845.82Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.768.7429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.733.73Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.363.9629,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.5810.85Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.485.5121,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.933.666,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-1.08Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.970.33Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.011.7821,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-4.94Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-6.3622,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-8.666,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.347.54Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.0815.0522,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.4611Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.421022,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.220.98312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2126.97Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.7724.48Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.2222.3722,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$2718922.59312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1123.83312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.326.82Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.4819.8424,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.7821.2922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6224.72Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3631.9323,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7526.1311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$278122.5922,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.5216.71311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.2819.2422,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.5818.7215,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.6620.89311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$278122.5924,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.575.05308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$307510.33Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.5117.518,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.9811.94308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.77.89Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-0.4521,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-5.216,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-4.28Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-0.7821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.38905.4818,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.3511.56308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$307510.33Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.8810.5218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-1.87313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-3.53Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.331.7518,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.60.6121,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.495.116,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.90.36318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.580.21Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-0.1521,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-0.1521,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-1.6619,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-6.31318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-4.36Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-2.117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-2.117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-0.6913,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-1.25323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-7.23Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-7.7517,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-9.2413,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-8.46
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-9.83
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-9.076,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-10.27
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-10.37
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-11.697,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-11327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-9.19
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-7.626,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-3.61
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-3.837,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-4.61Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-8.1117,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-8.0312,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$307510.33Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.4819.1112,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.4315.8612,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.5819.15
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.417.677,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.516.552,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.9616.22
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.5317.58
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.0818.0914,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.5415.056,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.518.2117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.718.7214,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.719.32333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.9519.11Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$288418.2117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.6818.896,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1223.37288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.722.87338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.2623.0936,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.5221.16288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.221.51Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.119.02288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$288418.2117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.5515.6514,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.80.06Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-6.1343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-2.0417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-2.0111,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-4.8914,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-1.95348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.454.45Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-5.4614,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-5.972,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-5.4353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-4.67Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.238.5614,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-7.86,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-3.33358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-4.78Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-6.47Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-7.9314,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-0.45363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-0.78Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-0.78Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-1.31Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-2.5613,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-2.07367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.522.6
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.490.2126,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-2.3
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-3.3Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-1.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.0410.48
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.69.53Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.1814.6513,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.6916.34
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.4217.336,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.6518.51372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.9519.11Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.9818.318,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.815.77Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.79.3113,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.410.04377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.3510.08Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.3510.08Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.410.04377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.086.519,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.56.6Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.8510.5513,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.749.93
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.099.93
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.099.93
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.111.04
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.3711.04
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.0111.04
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.1913.9
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.613.9
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.7113.9
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.528516.14Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.717.63382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.3817.96
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.817.96
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.117.96
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.6512.82
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.8512.7
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.3412.7
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.7615.0920,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.7115.0920,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.626.43Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2425.57
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0925.57
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1325.57
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.626.43Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1825.0514,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.0220.326,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.125.28Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.124.34Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.723.78382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$282818.2117,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.8520.197,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.220.54Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1527.16387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.821.29Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.4815.777,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.6317.71
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.7219.67
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.1617.71
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3127.75
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1627.6
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7827.75
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3526.97392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.9819.45
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.6619.45
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.5321.02
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.1921.56
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.4821.56
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.821.51Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5223.55
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.524.447,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7427.6
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4927.6
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9435.21
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1649.916,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.852.11392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.644.98Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5548.367,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.259.06Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.249.917,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.143.79392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.835.43Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1531.047,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1531.047,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.925.146,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.0519.88392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.220.981,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.719.327,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.622.05392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9127.7518,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.828.841,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1226.38
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9226.38
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6826.34
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4526.437,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.6121.07
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.0621.02
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.321.02
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7529.55392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.482519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.224.16Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8327.657,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0827.11Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.930.42Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9229.85Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3230.73Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.227.5Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.5523Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2535.38Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3236.27Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7939.13Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3236.27Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.429.2Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3827.16Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0831.19Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7832.08Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1232.08Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4430.06Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0628.84Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.728.84Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9241.51Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2141.51Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3542.24Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5147.05Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0847.05Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244449.1Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.256.5Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.256.5Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8757.17Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.652.32Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6549.57Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6845.75Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.247.37Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.646.2Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514089.14Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.183.48Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.481.17Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279137.28Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.78119.21Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.4122.6Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.53120.52Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.15123.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.92123.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64128.91Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13128.91Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07130.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73130.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81127.96Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3127.96Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.94120.81Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.61120.81Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.56119.64Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.42122.9Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.76122.9Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.5120.67Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.2125.02Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58126.56Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23126.56Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.28124.41Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2158.39Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41153.64Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283133.92Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04135.59Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.24109.76Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.68108.57Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.2112.04Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.8113.41Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.496.21Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.595.86Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1496.09Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538970.18Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338671.5Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4870.71Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3270.18Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7966.92Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1594.13Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7994.13Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.692.11Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7889.03Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5294.59Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9494.59Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3493.12Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2591.88Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8789.47Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.664.51Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9562.33Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8462.1Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8863.54Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7863.38Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.272.31Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3365.17Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8865.58Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5865.5Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2560.29Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.162.1Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9260.21Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179856.35Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6556.65Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6559.67Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0460.14Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1464.51Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8559.36Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7465.67Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2765.67Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6865.67Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9165.67Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6569.48Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010065.5Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4469.83Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8869.74Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.869.83Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8869.83Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0470.44Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1769.92Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.11106.75
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.11106.75
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6281.17
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8987.11
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199574.21
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9184.2
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6284.2
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8184.2
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4584.2
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.664.51
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5270.09
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7269.31
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.169.31
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4669.31
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8269.31
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2867.85
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6429.96
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9730.99
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.870.62
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5573.03
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.653.81
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3660.68
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3660.68
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.258.75
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8570.53
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0264.11
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1171.95
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1171.95
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.879.89
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9866.58
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9866.58
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.665.09
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.764.11
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3262.57
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.447.05
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3546.01
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4851.9
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6544.35
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0345.88
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0839.84
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460636.55
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1239.31
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125257.62
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1571.86
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20265.5
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0466.16
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7766.25
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4666.25
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0566.25
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2883.99
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522576.53
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.271.77
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6492.22
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0875.69
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.861.62
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1563.62
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2246.59
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1243.85
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1944.29
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4829.6
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8946.07
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9343.29
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4150.45
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8443.48
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4442.61
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9264.19
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8466.83
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.468.02
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2868.11
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5969.14
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3776.44
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9266.25
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9970.27
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1656.28
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018874.12
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9272.76
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2988.5
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.89102.82
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.87102.82
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.1102.82
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.09102.82
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7799.52
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6699.52
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.999.52
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6299.52
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.61113.55
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.02113.55
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.6113.55
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.84113.55
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.95113.55
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.95113.55
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4499.16
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.5102.94
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2491.66
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4392.89
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1581.07
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8781.07
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.381.07
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2881.07
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2681.07
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.280.38
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1582.97
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8882.97
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.482.87
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0982.97
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4182.97
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1682.07
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2668.62
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1478.53
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.278.53
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7378.53
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0478.53
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0478.53
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5781.37
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5681.37
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0481.37
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6781.37
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5581.37
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4482.67
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8174.49
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8553.38
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4553.38
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1753.38
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0753.38
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.750.66
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3860.68
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8860.68
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1360.68
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2660.68
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72135.59Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21135.59Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17135.59Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79175.83Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21175.83Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK